Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Minerva Medica|October 13, 1986
[Prevalence of peptic ulcer in patients with various hepatopathies]A Andriulli, A Arrigoni, T Gindro, et al.The Journal of Nuclear Medicine and Allied Sciences|July 1, 1989
Alpha-fetoprotein in hepatic pathology and hepatocarcinomaP Piantino, A Arrigoni, M R Brunetto, et al.Minerva Medica|January 1, 1990
[Intestinal ischemia: nosographic framework and risk factors]A Andriulli, A Pera, T Gindro, et al.Digestion|January 1, 1989
Canrenone and androgen receptor-active materials in plasma of cirrhotic patients during long-term K-canrenoate or spironolactone therapyA Andriulli, A Arrigoni, T Gindro, et al.The International Journal of Biological Markers|July 1, 1988
Pattern analysis of serum alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma in liver cirrhosisA Arrigoni, A Andriulli, T Gindro, et al.Minerva Gastroenterologica E Dietologica|April 1, 1991
[Eosinophilic gastroenteritis and ascites. Clinical case]A Ottobrelli, M Lagget, A Arrigoni, et al.The American Journal of Gastroenterology|June 1, 1986
CA 19-9 assay in differential diagnosis of pancreatic carcinoma from inflammatory pancreatic diseasesP Piantino, A Andriulli, T Gindro, et al.Hepatology (Baltimore, Md.)|August 1, 1994
Monoethylglicinexylidide test: a prognostic indicator of survival in cirrhosisA Arrigoni, T Gindro, G Aimo, et al.Digestion|January 1, 1986
Prospective evaluation of the diagnostic efficacy of CA 19-9 assay as a marker for gastrointestinal cancersA Andriulli, T Gindro, P Piantino, et al.European Journal of Gastroenterology & Hepatology|February 21, 1998
Monoethyl glycine xylidide (MEGX) test evaluation in primary biliary cirrhosis: comparison with Mayo scoreT Gindro, A Arrigoni, G Martinasso, et al.Pageof 1